Systematic scoping review reveals published clinical trial characteristics in post-kala-azar dermal leishmaniasis, highlighting the feasibility of an individual participant-level data platform.
Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis which can occur after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL endemic areas. We conducted a systematic scoping review to assess the characteristics of published PKDL clinical studies, understand the scope of research and explore the feasibility and value of developing a PKDL individual patient data (IPD) platform.
No takes yet. Share an insight, caveat, or question.
Singh-Phulgenda et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: